Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medi-Weightloss operates a physician-supervised medical weight loss program with over 100 clinics across the US. Their evidence-based approach combines individualized nutrition plans (high-protein/low-carb diets), prescription medications when appropriate (including new FDA-approved anti-obesity drugs like semaglutide and tirzepatide), supplements, vitamin/nutrient injections, and ongoing clinical support. Clinical outcomes published by the company show an average 14% reduction in body weight after 13 weeks on their program. Additional benefits include reductions in BMI (~5 points), body fat (~12%), blood sugar (~4%), waist circumference (~5 inches), blood pressure improvement, and up to a 45% reduction or elimination of metabolic syndrome risk.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medi-Weightloss.